Clinical Trial Update: Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating colchicine for heart failure with preserved ejection fraction has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: I.M. Sechenov First Moscow State Medical University | Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction, Colchicine | Phase 1, Phase 2 | Status: COMPLETED